Screening continues even with low life expectancy

IN THE first population-based study to examine cancer screening among people with different life expectancies, researchers also found concerning rates of screening among those likely to die within five years.

Data was drawn from national health surveys from 2000–10.

Among participants with a risk of dying in the next nine years, 64% were screened for prostate cancer (ranging from 55% for those with high mortality risk to 70% for those with a lower risk), breast cancer screening ranged from 38–74%, cervical screening from 31–70% and colorectal screening from 41–51%.

JAMA Intern